Unknown

Dataset Information

0

Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.


ABSTRACT: To systematically evaluate the whole-transcriptome sequencing data of cholangiocarcinoma (CHOL) to gain more insights into the transcriptomic landscape and molecular mechanism of this cancer, we performed whole-transcriptome sequencing based on the tumorous (C) and their corresponding non-tumorous adjacent to the tumors (CP) from eight CHOL patients. Subsequently, differential expression analysis was performed on the C and CP groups, followed by functional interaction prediction analysis to investigate gene-regulatory circuits in CHOL. In addition, The Cancer Genome Atlas (TCGA) for CHOL data was used to validate the results. In total, 2,895 differentially expressed messenger RNAs (dif-mRNAs), 56 differentially expressed microRNAs (dif-miRNAs), 151 differentially expressed long non-coding RNAs (dif-lncRNAs), and 110 differentially expressed circular RNAs (dif-circRNAs) were found in CHOL samples compared with controls. Enrichment analysis on those differentially expressed genes (DEGs) related to miRNA, lncRNA, and circRNA also identified the function of spliceosome. The downregulated hsa-miR-144-3p were significantly enriched in the competing endogenous RNA (ceRNA) complex network, which also included 7 upregulated and 13 downregulated circRNAs, 7 upregulated lncRNAs, and 90 upregulated and 40 downregulated mRNAs. Moreover, most of the DEGs and a few of the miRNAs (such as hsa-miR-144-3p) were successfully validated by TCGA data. The genes involved in RNA splicing and protein degradation processes and miR-144-3p may play fundamental roles in the pathogenesis of CHOL.

SUBMITTER: Chu KJ 

PROVIDER: S-EPMC7390861 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Whole-Transcriptome Sequencing Identifies Key Differentially Expressed mRNAs, miRNAs, lncRNAs, and circRNAs Associated with CHOL.

Chu Kai-Jian KJ   Ma Yu-Shui YS   Jiang Xiao-Hui XH   Wu Ting-Miao TM   Wu Zhi-Jun ZJ   Li Zhi-Zhen ZZ   Wang Jing-Han JH   Gao Qing-Xiang QX   Yi Bin B   Shi Yi Y   Wang Hui-Min HM   Gu Li-Peng LP   Zhang Su-Qing SQ   Wang Gao-Ren GR   Liu Ji-Bin JB   Fu Da D   Jiang Xiao-Qing XQ  

Molecular therapy. Nucleic acids 20200627


To systematically evaluate the whole-transcriptome sequencing data of cholangiocarcinoma (CHOL) to gain more insights into the transcriptomic landscape and molecular mechanism of this cancer, we performed whole-transcriptome sequencing based on the tumorous (C) and their corresponding non-tumorous adjacent to the tumors (CP) from eight CHOL patients. Subsequently, differential expression analysis was performed on the C and CP groups, followed by functional interaction prediction analysis to inve  ...[more]

Similar Datasets

| S-EPMC10098162 | biostudies-literature
| S-EPMC10047933 | biostudies-literature
| S-EPMC10019506 | biostudies-literature
| S-EPMC8557489 | biostudies-literature
| S-EPMC6413561 | biostudies-literature
| S-EPMC9851049 | biostudies-literature
| S-EPMC7609633 | biostudies-literature
| S-EPMC5946474 | biostudies-literature
| S-EPMC4746671 | biostudies-literature
| S-EPMC9407282 | biostudies-literature